Titan Pharmaceuticals Inc (TTNP)

[Doctor Detroit]

I don't know, but I assume Canaccord is leading the process. I assume Titan hasn't got the rights back yet, and that Braeburn is looking for some sort of compensation for the development work done to date. They mention "transaction" or "license agreement" in the press release They could sell the entire company, all the rights to probuphine or out-license probuphine again.

In terms of partners, Opiant is too small. Indivior probably wouldn't be interested as they will be pushing their own injectables, and Braeburn is likely to try to negotiate to prevent that from happenining. Alkermes is an interesting thought. The implant would give them a buprenorphine product that they don't have and allow them to play in that market.